A synthetic hydroxypropenone inhibits nitric oxide, prostaglandin E2, and proinflammatory cytokine synthesis

Immunopharmacology and Immunotoxicology

Volumn 32, Issue 3, 2010, Pages 495-506

  Liew, Choi Yi ^a   Tham, Chau Ling ^a   Lam, Kok Wai ^a   Mohamad, Azam Shah ^a   Kim, Min Kyu ^a   Cheah, Yoke Kqueen ^a   Zakaria, Zainul Amiruddin ^a   Sulaiman, Mohd Roslan ^a   Lajis, Md Nordin ^a   Israf, Daud Ahmad ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

COX 2; Cytokines; Hydroxypropenone; INOS; RAW 264.7; U937

Indexed keywords

BETA ACTIN; CHALCONE DERIVATIVE; CYCLOOXYGENASE 2; CYTOKINE; GAMMA INTERFERON; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HYDROXYPROPENONE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; PHORBOL 13 ACETATE 12 MYRISTATE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOWN REGULATION; DRUG SELECTIVITY; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; MEDIATOR RELEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CHALCONES; CYCLOOXYGENASE 2; CYTOKINES; DINOPROSTONE; DOWN-REGULATION; FURANS; HUMANS; INTERFERON-ALPHA; INTERFERON-GAMMA; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PROPIOPHENONES; TUMOR NECROSIS FACTOR-ALPHA; U937 CELLS;

EID: 77954544871     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.3109/08923970903575708     Document Type: Article

References (40)

1. Förstermann, U., Li, H., Schwarz, P.M., Kleinert, H. NO synthesis and NOS regulation. In Signal Transduction by Reactive Oxygen and Nitrogen Species. Forman, H.J., Fukuto, J., Torres, M., Eds.; Dordrecht: Kluwer Academic Publishers, 2003:119-154.
2. Kleinert, H., Pautz, A., Linker, K., Schwarz, P.M. Regulation of the expression of inducible nitric oxide synthase. Eur. J. Pharmacol. 2004, 500, 255-266.
3. Clancy, R.M., Varneika, B., Rediske, J., Stoyanovsky, D., Wink, D., Abramson, S.B. The nitric oxide (NO) paradox resolved by Angelis salt: tissue injury depends upon NO redox state. Arth. Rheum. 1998, 41, S143.
4. Stow, J.L., Low, P.C., Offenhäuser, C., Sangermani, D. Cytokine secretion in macrophages and other cells: pathways and mediators. Immunobiology 2009, 214, 601-612.
5. Agarwal, V., Malaviya, A.N. Cytokine network and its manipulation in rheumatoid arthritis. J. Indian Rheumatol. Assoc. 2005, 13, 86-91.
6. Wolf, A.M., Wolf, D., Rumpold, H., Ludwiczek, S., Enrich, B., Gastl, G., Weiss, G., Tilg, H.The kinase inhibitor imatinib mesylate inhibits TNF-? production in vitro and prevents TNF-dependent acute hepatic inflammation. Proc. Natl. Acad. Sci. USA 2005, 202, 13622-13627.
7. Cheon, H., Rho, Y.H., Choi, S.J., Lee, Y.H., Song, G.G., Sohn, J., Won, N.H., Ji, J.D. Prostaglandin E2 augments IL-10 signaling and function. J. Immunol. 2006, 177, 1092-1100.
8. Na, H.J., Lee, G., Oh, H.Y., Jeon, K.S., Kwon, H.J., Ha, K.S., Lee, H., Kwon, Y.G., Kim, Y.M. 4-O-Methylgallic acid suppresses inflammation-associated gene expression by inhibition of redox- based NF-kappaB activation. Int. Immunopharmacol. 2006, 6, 1597-1608.
9. Makarov, S.S. NF-?B as a therapeutic target in chronic inflammation: recent advances. Mol. Med. Tod. 2000, 6, 441-448.
10. Abate, A., Oberle, S., Schröder, H. Lipopolysaccharide-induced expression of cyclooxygenase-2 in mouse macrophages is inhibited by chloromethylketones and a direct inhibitor of NF-kappa B translocation. Prostaglandins Other Lipid Mediat. 1998, 56, 277-290.
11. Pando, M.P., Verma, I.M. Signal-dependent and -independent degradation of free and NF-kappa B-bound IkappaBalpha. J. Biol. Chem. 2000, 275, 21278-21286.
12. Nasuhara, Y., Adcock, I.M., Catley, M., Barnes, P.J., Newton, R. Differential IkappaB kinase activation and IkappaBalpha degradation by interleukin-1beta and tumor necrosis factor-alpha in human U937 monocytic cells. Evidence for additional regulatory steps in kappaB-dependent transcription. J. Biol. Chem. 1999, 274, 19965-19972. (Pubitemid 29327783)
13. Griscavage, J.M., Wilk, S., Ignarro, L.J. Inhibitors of the proteasome pathway interfere with induction of nitric oxide synthase in macrophages by blocking activation of transcription factor NF-kappa B. Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 3308-3312.
14. Kiemer, A.K., Hartung, T., Huber, C., Vollmar, A.M. Phyllanthus amarus has anti-inflammatory potential by inhibition of iNOS, COX-2, and cytokines via the NF-kappaB pathway. J. Hepatol. 2003, 38, 289-297.
15. Lee, Y.W., Han, S.H., Lee, M., Yang, K.H., Kim, H.M., Jeon, Y.J. 2-Amino-3-methylimidazo[4,5-f ]quinoline inhibits nitric oxide production in lipopolysaccharide-stimulated RAW 264.7 cells by blocking p38 kinase activation. Cancer Lett. 2000, 156, 133-139.
16. Yun, K.J., Kim, J.Y., Kim, J.B., Lee, K.W., Jeong, S.Y., Park, H.J., Jung, H.J., Cho, Y.W., Yun, K., Lee, K.T. Inhibition of LPS-induced NO and PGE2 production by asiatic acid via NF-kappa B inactivation in RAW 264.7 macrophages: possible involvement of the IKK and MAPK pathways. Int. Immunopharmacol. 2008, 8, 431-441.
17. Kumar, S., Sharma, A., Madan, B., Singhal, V., Ghosh, B. Isoliquiritigenin inhibits IkappaB kinase activity and ROS generation to block TNF-alpha induced expression of cell adhesion molecules on human endothelial cells. Biochem. Pharmacol. 2007, 73, 1602-1612.
18. Ko, H.H., Tsao, L.T., Yu, K.L., Liu, C.T., Wang, J.P., Linc, C.N. Structure-Activity relationship studies on chalcone derivatives: The potent inhibition of chemical mediators release. Bioorg. Med. Chem. 2003, 11, 105-111.
19. Takahashi, T., Takasuka, N., Iigo, M., Baba, M., Nishino, H., Tsuda, H., Okuyama, T. Isoliquiritigenin, a flavonoid from licorice, reduces prostaglandin E2 and nitric oxide, causes apoptosis, and suppresses aberrant crypt foci development. Cancer Sci. 2004, 95, 448-453.
20. Israf, D.A., Khaizurin, T.A., Syahida, A., Lajis, N.H., Khozirah, S. Cardamonin inhibits COX and iNOS expression via inhibition of p65NF-kappaB nuclear translocation and Ikappa-B phosphorylation in RAW 264.7 macrophage cells. Mol. Immunol. 2007, 44, 673-679.
21. Kim, H.P., Son, K.H., Chang, H.W., Kang, S.S. Anti-inflammatory plant flavonoids and cellular action mechanisms. J. Pharmacol. Sci. 2004, 96, 229-245.
22. Rajendran, M., Manisankar, P., Gandhidasan, R., Murugesan, R. Free radicals scavenging efficiency of a few naturally occurring flavonoids: a comparative study. J. Agric. Food Chem. 2004, 52, 7389-7394.
23. Hendriks, J.J., de Vries, H.E., van der Pol, S.M., van den Berg, T.K., van Tol, E.A., Dijkstra, C.D. Flavonoids inhibit myelin phagocytosis by macrophages; a structure-activity relationship study. Biochem. Pharmacol. 2003, 65, 877-885.
24. Nagasaka, R., Chotimarkorn, C., Shafiqul, I.M., Hori, M., Ozaki, H., Ushio, H. Anti-inflammatory effects of hydroxycinnamic acid derivatives. Biochem. Biophys. Res. Commun. 2007, 358, 615-619.
25. Kim, Y.H., Kim, J., Park, H., Kim, H.P. Anti-inflammatory activity of the synthetic chalcone derivatives: inhibition of inducible nitric oxide synthase-catalyzed nitric oxide production from lipopolysaccharide-treated RAW 264.7 cells. Biol. Pharm. Bull. 2007, 30, 1450-1455.
26. Ban, H.S., Suzuki, K., Lim, S.S., Jung, S.H., Lee, S., Ji, J., Lee, H.S., Lee, Y.S., Shin, K.H., Ohuchi, K. Inhibition of lipopolysaccharide- induced expression of inducible nitric oxide synthase and tumor necrosis factor-alpha by 2?-hydroxychalcone derivatives in RAW 264.7 cells. Biochem. Pharmacol. 2004, 67, 1549-1557.
27. Herencia, F., Ferrándiz, M.L., Ubeda, A., Guillén, I., Dominguez, J.N., Charris, J.E., Lobo, G.M., Alcaraz, M.J. Novel anti- inflammatory chalcone derivatives inhibit the induction of nitric oxide synthase and cyclooxygenase-2 in mouse peritoneal macrophages. FEBS Lett. 1999, 453, 129-134.
28. Nowakowska, Z. A review of anti-infective and anti-inflammatory chalcones. Eur. J. Med. Chem. 2007, 42, 125-137.
29. Ko, H.H., Tsao, L.T., Yu, K.L., Liu, C.T., Wang, J.P., Lin, C.N. Structure-activity relationship studies on chalcone derivatives. the potent inhibition of chemical mediators release. Bioorg. Med. Chem. 2003, 11, 105-111.
30. Tran, T.D., Park, H., Kim, H.P., Ecker, G.F., Thai, K.M. Inhibitory activity of prostaglandin E2 production by the synthetic 2-hydroxychalcone analogues: Synthesis and SAR study. Bioorg. Med. Chem. Lett. 2009, 19.
31. Lee, S.H., Seo, G.S., Sohn, D.H. Inhibition of lipopolysaccharideinduced expression of inducible nitric oxide synthase by butein in RAW 264.7 cells. Biochem. Biophys. Res. Commun. 2004, 323, 125-132.
32. Herencia, F., López-García, M.P., Ubeda, A., Ferrándiz, M.L. Nitric Oxide-scavenging properties of some chalcone derivatives. Nitric Oxide 2002, 6, 242-246.
33. Jahng, Y., Zhao, L.X., Moon, Y.S., Basnet, A., Kim, E.K., Chang, H.W., Ju, H.K., Jeong, T.C., Lee, E.S. Simple aromatic compounds containing propenone moiety show considerable dual COX/5- LOX inhibitory activities. Bioorg. Med. Chem. Lett. 2004, 14, 2559-2562.
34. Lee, E.S., Ju, H.K., Moon, T.C., Lee, E., Jahng, Y., Lee, S.H., Son, J.K., Baek, S.H., Chang, H.W. Inhibition of nitric oxide and tumor necrosis factor-alpha (TNF-alpha) production by propenone compound through blockade of nuclear factor (NF)-kappa B activation in cultured murine macrophages. Biol. Pharm. Bull. 2004, 27, 617-620.
35. Park, S.K., Murphy, S. Nitric oxide synthase type II mRNA stability is translation- and transcription-dependent. J. Neurochem. 1996, 67, 1766-1769.
36. Andrew, R., Clark, A.R., Jonathan, L.E., Dean Saklatvala, J. Posttranscriptional regulation of gene expression by mitogen-activated protein kinase p38. FEBS Letters 2003, 546, 37-44.
37. Handel, M.L., Girgis, L. Transcription factors. Best Pract. Res. Clin. Rheumatol. 2001, 15, 657-675.
38. Liu, Z., Fan, Y., Wang, Y., Han, C., Pan, Y., Huang, H., Ye, Y., Luo, L., Yin, Z. Dipyrithione inhibits lipopolysaccharide-induced iNOS and COX-2 up-regulation in macrophages and protects against endotoxic shock in mice. FEBS Lett. 2008, 582, 1643-1650. 10.1016/j.febslet.2008.04.016
39. Park, S.W., Sung, M.W., Heo, D.S., Inoue, H., Shim, S.H., Kim, K.H. Nitric oxide upregulates the cyclooxygenase-2 expression through the cAMP-response element in its promoter in several cancer cell lines. Oncogene 2005, 24, 6689-6698.
40. Kim, S.F., Huri, D.A., Snyder, S.H. Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2. Science 2005, 310, 1966-1970. 10.1126/Science.1119407 (Pubitemid 43005992)